Showing results (391-400 of 419) with videos related to

Sort By:
Pageof 42
Plos One|March 18, 2016
Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of FranceDavid Pasquier, Laurence Boutaud de la Combe-Chossiere, Damien Carlier, et al.
ACS Nano|March 13, 2023
A High-Entropy Oxide as High-Activity Electrocatalyst for Water OxidationMohana V Kante, Moritz L Weber, Shu Ni, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II studyEls Verdegaal, Monique K van der Kooij, Marten Visser, et al.
Stem Cell Reports|March 27, 2026
3D Vessels-on-Chip using isogenic hiPSC-derived VSMCs reveal NOTCH3-driven alterations in brain small vessel diseaseMarc Vila Cuenca, Theano Tsikari, Minne N Cerfontaine, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|April 10, 2024
In Situ X-ray Absorption Spectroscopy of LaFeO<sub>3</sub> and LaFeO<sub>3</sub>/LaNiO<sub>3</sub> Thin Films in the Electrocatalytic Oxygen Evolution ReactionQijun Che, Iris C G van den Bosch, Phu T P Le, et al.
Journal for Immunotherapy of Cancer|November 10, 2023
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancerEls M E Verdegaal, Saskia J Santegoets, Marij J P Welters, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2019
Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulatorsFrançois P Bischoff, Adriana Ingrid Velter, Garrett Minne, et al.
BMJ Open|November 25, 2020
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trialMonique K van der Kooij, Els M E Verdegaal, Marten Visser, et al.
Bioconjugate Chemistry|March 12, 2024
Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung CancerNatalie Y Luo, Rachel L Minne, Joseph P Gallant, et al.
Neurology. Genetics|March 30, 2026
Expanding the Clinicoradiologic Phenotype of the <i>CTSA</i>-Associated Small Vessel Disease CARASAL: A Comparison With CADASILMinne N Cerfontaine, Gido Gravesteijn, Remco J Hack, et al.
Pageof 42